Dynavax Technologies (DVAX) Cash from Operations: 2009-2024
Historic Cash from Operations for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $66.5 million.
- Dynavax Technologies' Cash from Operations rose 73.78% to $33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.6 million, marking a year-over-year increase of 232.39%. This contributed to the annual value of $66.5 million for FY2024, which is 33.86% down from last year.
- According to the latest figures from FY2024, Dynavax Technologies' Cash from Operations is $66.5 million, which was down 33.86% from $100.6 million recorded in FY2023.
- Over the past 5 years, Dynavax Technologies' Cash from Operations peaked at $335.5 million during FY2021, and registered a low of -$92.3 million during FY2020.
- Its 3-year average for Cash from Operations is $76.6 million, with a median of $66.5 million in 2024.
- In the last 5 years, Dynavax Technologies' Cash from Operations skyrocketed by 463.71% in 2021 and then crashed by 81.31% in 2022.
- Over the past 5 years, Dynavax Technologies' Cash from Operations (MRY) stood at -$92.3 million in 2020, then soared by 463.71% to $335.5 million in 2021, then tumbled by 81.31% to $62.7 million in 2022, then surged by 60.35% to $100.6 million in 2023, then crashed by 33.86% to $66.5 million in 2024.
- Its Cash from Operations was $66.5 million in FY2024, compared to $100.6 million in FY2023 and $62.7 million in FY2022.